The initial clearance of the NavioPFS surgical system is for unicondylar knee replacement surgery.
“We could not be any more excited to gain FDA clearance of our NavioPFS system,” said Mr. Eric B. Timko, president and CEO of Blue Belt Technologies, in the release. “The entire Blue Belt team, including our physician advisors, has remained committed to providing orthopedic surgeons and hospitals a more precise and consistent technique to perform UKR procedures that takes into consideration the current economic environment in our healthcare system. We are confident that NavioPFS accomplishes these goals, and provides excellent results for patients.”
The company will commence commercialization in the United States immediately for the UKR application and said it is continuing to develop other applications where the system can be used to perform precision bone shaping procedures.
Blue Belt Technologies, a technology company focused on commercializing a precision robotic solution for orthopedic surgery, is headquartered in Pittsburgh, Pa.
Related Articles on FDA Clearances:
LENSAR Cataract Laser System Receives FDA Clearance for Corneal Incisions
Merit Medical Receives FDA Clearance for the Endovascular Snare System
Ethicon Receives FDA Clearance for Sealant Patch
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.